Global Hyaluronic Acid Market Size, Share, Opportunities, And Trends By Application (Tissue Engineering, Osteoarthritis Treatment, Dermal Filler, Others) And By Geography - Forecasts From 2025 To 2030

The hyaluronic acid market is anticipated to expand at a high CAGR over the forecast period.

Hyaluronic acid (HA) is naturally available in the human body. In eyes and joints, HA is found in the highest concentrations. The substance has the ability to keep skin plump and moist. Hence, it is utilized by many cosmetic surgeons in the form of injectables to reduce aging on the skin.

The growing global geriatric population is projected to surge the market growth during the forecast period. The presence of companies offering advanced hyaluronic acid solutions for customers worldwide is further augmenting the market growth during the forecast period. Hyaluronic acid can be found in the form of serums, sheet masks, and dermal fillers. Popular brand names for hyaluronic acid fillers include Juvederm, Elevess, Puragen, and Captique among others. The growing adoption of minimally invasive procedures for cosmetic procedures is further propelling the market growth during the forecast period.

On the basis of geography, the market is segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific region. North America is projected to hold a significant market share owing to the early adoption of technologies and innovation. Additionally, the substantial aging population along with increasing susceptibility to age-associated diseases like osteoarthritis is further contributing to fueling the market demand during the forecast period. The Asia Pacific region is estimated to account for a substantial market share owing to the increasing interest in the adoption of anti-aging products.

The novel coronavirus infection scenario is predicted to impede the market growth in 2020 owing to the lockdown measures. The closure of aesthetic and cosmetic clinics has further put an impact on affecting the market growth amid the COVID-19 pandemic situation compared to the pre-COVID-19 situation.

The soaring dermal filler procedures worldwide are augmenting the growth of the global hyaluronic acid market during the forecast period.

The market is projected to soar with the growing number of dermal filler procedures in the world. There is an increasing interest among consumers to look young and thus this has surged the demand for cosmetic procedures that include hyaluronic acid dermal filler consumption, further propelling the market demand during the forecast period. The dermal fillers help in filling wrinkles and are utilized to add volume to the soft tissues, thus giving them a full and voluptuous look. These gel injections are inserted in different areas of the body including lips, cheeks, jawline, and lips.

Other factors fueling the demand for dermal filler procedures include the immediate effects observed after application. This reduces the signs of aging and provides consumers the near-instant satisfaction. The currently growing selfie trend and uploading it on the social media platform have raised the growth prospects of these procedures. Consumers seek measures that make them look beautiful while posting pictures on social media platforms. The increasing aging worldwide is further augmenting the market growth demanding dermal filler procedures during the forecast period. The total population 65 years of age and above is predicted to surge from 55,11,19,375 in 2012 to 69,79,67,728 in 2019 (source: The World Bank).

The increasing interest of men to look their best, apart from women is further adding to surging the demand for dermal fillers, propagating the market growth during the forecast period. These groups of people are quite comfortable with the available aesthetic procedures offering innovative options to enhance their looks. Additionally, the convenient methods to administer hyaluronic acid into the human skin are further propelling the market demand owing to the consumer-friendliness of the cosmetic procedures that are minimally invasive and are least painful offering huge gains.

With the increasing disposable income worldwide, especially, in the developing regions of the world, the demand for dermal fillers is continuing to grow. This is mainly attributed to increasing consumer spending ability, further offering them options to look above their basic expenditures and hence, are willing to spend on sophisticated cosmetic procedures. According to the National Bureau of Statistics Data, the per capita consumer spending in China rose to 21,559 yuan in 2019, an increase of 5.5% y-o-y.

There is a wide availability of dermal fillers in the market, these include temporary, permanent, and semi-permanent fillers. Most of the non-permanent fillers are safer to use and are FDA-approved, these include hyaluronic-based fillers as well. 

The presence of companies offering innovative hyaluronic acid-based products is fueling the market growth during the forecast period.

Galderma, focused on offering science-based solutions for skin health through its Restylane® brand offers a diverse range of hyaluronic-acid-based commodities segregated into two product groups namely, Restylane fillers and Restylane Skinboosters.

The fillers category is a combination of two unique technologies involving OBT and NASHTA™. These have further established safety profiles for more than two decades of experience and Offers high patient satisfaction with around 40 million treatments in the world. The product portfolio includes Restylane Fynesse™, Restylane Refyne™, Restylane, and Restylane Volyme™ for the restoration of youthful appearance that includes filling fine lines and wrinkles and replacing the lost fullness and volume due to aging. Restylane Defyne™, Restylane Lyft™, and Restylane Kysse™ are used for enhancing the appearance for the creation of harmony and balance and for the enhancement of the shape, contour, and definition.

The Skinboosters category offers solutions for skin rejuvenation for delivering hydration and skin imperfection improvement, thus leading to radiant and healthy skin.

Humedix Co., Ltd. offers hyaluronic acid as the active pharmaceutical ingredient for applications in eye drops, ophthalmology injections, beauty fillers, and osteoarthritis drugs.

Kewpie Corporation offers hyaluronic acid for cosmetic applications. Products include HAbooster™, Hyalo-Oligo®, Hyaloveil®-P, and Hyalorepair®. The HAbooster is a collagen cycle accelerator hyaluronic acid, a novel product having a super low molecular weight of around 2000. Further promoting the collagen cycle and increasing skin moisture. The low molecular hyaluronic acid, Hyalo-oligo has an average molecular weight lesser than 10,000. It soaks into the skin's hard layer and imparts moisture from inside the skin. Hyaloveli-P is a hyaluronic acid containing adsorptive properties that stay in hair and on the skin even when rinsed with water. Hence this contributes to sustained moisture even after the washing-off of the hyaluronic acid. Hyalorepair is a lamellar structure reviving hyaluronic acid that contains the properties of hydrophilic and hydrophobic groups. This further contributed to enhancing and reviving the skin’s barrier functionality, further resulting in smoother skin.

Significant product launches indicating continuous innovation in the field of hyaluronic acid are further augmenting the market growth during the forecast period in addition to offering strong prospects for generating high revenues.

The launching of a skincare capsule by Taut USA in 2019 was announced. The capsule, TautHydrate is a one hundred percent vegan hyaluronic acid and grape seed extract supplement. The product is designed for skin hydration and plumping from within. The capsule is based on the plant-derived and proprietary fermentation procedure of non-animal origin. This is further highly pure and of low molecular weight, hence is capable of penetrating skin cells. The product is focused on vegan customers demanding natural and clean products. Additionally, the product is an excellent alternative for hyaluronic acid-based injections as everyone is not capable of affording highly-priced fillers.

In 2019, Alma declared the launch of Profhilo®. This is an advanced hyaluronic acid-based product for aesthetic procedures in Hong Kong. The product is an entirely novel injectable category known as remodeling, it works through the engagement with the body’s receptors and helps in the stimulation of collagen growth. In comparison to the standard dermal fillers, the product is capable of distributing itself conveniently within the tissues of the skin. Thus, resulting in a healthier and more elastic skin for the patients. The overall product contains benefits derived from both the dermal filler world and skin rejuvenation treatment procedures.

In 2019, Protocol, the collagen brand announced the launch of innovative collagen products. This was declared with the launch of collagen and hyaluronic acid capsules. The product utilizes the advanced technology of verisol with bioactive collagen peptides in addition to the moisture-binding ingredient, hyaluronic acid. The formula is scientifically proven to reduce wrinkles and reduction in the appearance of fine lines, thus contributing to increasing skin elasticity and encouraging cell proliferation. Further resulting in healthy cells in less than four weeks. The product benefits include increasing pro-collagen production by more than 60%, enhancing skin elasticity by 15%, wrinkle reduction by 20%, improvement in wound healing after surgical intervention, reduction in the appearance of cellulite, and improvement of brittle nails.

In 2020, JW Pharmaceutical declared the launch of a hyaluronic acid filler, initium in South Korea. The product consists of 3 state product lines that include 2 bi-phasic products, and 1 mono-phasic product.

Segmentation:

• By Application
  • Tissue Engineering
  • Osteoarthritis Treatment
  • Dermal Filler
  • Others

• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Others
  • Middle East and Africa
    • UAE
    • Israel
    • Saudi Arabia
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Others

Allergan (AbbVie Inc.)

Sanofi

Seikagaku Corporation

Contipro a.s.

BioScience GmbH

Kewpie Corporation

Bohus BioTech AB

Humedix.Co.Ltd

Anika Therapeutics, Inc. 

Laboratoires Vivacy, S.A.S.

Cosmedica Skincare

Wellona Pharma

Plamed Green Science Group

Revitajal (Beauty Aesthetic Finland Oy)

Altergon Italy Srl